Compile Data Set for Download or QSAR
maximum 50k data
Found 2107 with Last Name = 'chattopadhyay' and Initial = 'ak'
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631769(US20230348426, Example 39)
Affinity DataEC50:  72nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631770(US20230348426, Example 40)
Affinity DataEC50:  0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631770(US20230348426, Example 40)
Affinity DataEC50:  2.60E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631771(US20230348426, Example 41 | US20230348426, Example...)
Affinity DataEC50:  0.600nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631771(US20230348426, Example 41 | US20230348426, Example...)
Affinity DataEC50:  110nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631772(US20230348426, Example 42)
Affinity DataEC50:  0.700nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631772(US20230348426, Example 42)
Affinity DataEC50:  730nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631773(US20230348426, Example 43)
Affinity DataEC50:  0.800nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631773(US20230348426, Example 43)
Affinity DataEC50: >5.00E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631771(US20230348426, Example 41 | US20230348426, Example...)
Affinity DataEC50:  1nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631771(US20230348426, Example 41 | US20230348426, Example...)
Affinity DataEC50:  10nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631775(US20230348426, Example 45)
Affinity DataEC50:  1nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631775(US20230348426, Example 45)
Affinity DataEC50:  4.30nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631776(US20230348426, Example 46)
Affinity DataEC50:  1nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631776(US20230348426, Example 46)
Affinity DataEC50:  2nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631777(US20230348426, Example 155 | US20230348426, Exampl...)
Affinity DataEC50:  1.10nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631777(US20230348426, Example 155 | US20230348426, Exampl...)
Affinity DataEC50:  150nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631778(US20230348426, Example 48)
Affinity DataEC50:  1.10nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631778(US20230348426, Example 48)
Affinity DataEC50:  940nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631779(US20230348426, Example 49)
Affinity DataEC50:  1.10nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631779(US20230348426, Example 49)
Affinity DataEC50:  2.00E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631780(US20230348426, Example 50)
Affinity DataEC50:  1.20nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631780(US20230348426, Example 50)
Affinity DataEC50:  1.70E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631781(US20230348426, Example 51)
Affinity DataEC50:  1.20nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631781(US20230348426, Example 51)
Affinity DataEC50:  5.50E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631782(US20230348426, Example 52)
Affinity DataEC50:  1.30nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631782(US20230348426, Example 52)
Affinity DataEC50:  27nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631783(US20230348426, Example 53 | US20230348426, Example...)
Affinity DataEC50:  1.40nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631783(US20230348426, Example 53 | US20230348426, Example...)
Affinity DataEC50:  2.30nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631784(US20230348426, Example 54)
Affinity DataEC50:  1.40nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631784(US20230348426, Example 54)
Affinity DataEC50:  820nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631785(US20230348426, Example 55)
Affinity DataEC50:  1.40nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631785(US20230348426, Example 55)
Affinity DataEC50:  8.60nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631783(US20230348426, Example 53 | US20230348426, Example...)
Affinity DataEC50:  1.40nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631783(US20230348426, Example 53 | US20230348426, Example...)
Affinity DataEC50:  4nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631787(US20230348426, Example 57)
Affinity DataEC50:  1.40nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631787(US20230348426, Example 57)
Affinity DataEC50:  0.0660nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631788(US20230348426, Example 58)
Affinity DataEC50:  1.5nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631788(US20230348426, Example 58)
Affinity DataEC50:  3.5nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631731(US20230348426, Example 1)
Affinity DataEC50:  28nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631731(US20230348426, Example 1)
Affinity DataEC50:  4.20E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631732(US20230348426, Example 2)
Affinity DataEC50:  22nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631732(US20230348426, Example 2)
Affinity DataEC50:  86nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631733(US20230348426, Example 3)
Affinity DataEC50:  29nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631733(US20230348426, Example 3)
Affinity DataEC50:  1.70E+3nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631734(N-((3S, 4R)-4-(2, 6-Difluoro-4-methoxyphenyl)-2-ox...)
Affinity DataEC50:  1.70nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631734(N-((3S, 4R)-4-(2, 6-Difluoro-4-methoxyphenyl)-2-ox...)
Affinity DataEC50:  290nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631734(N-((3S, 4R)-4-(2, 6-Difluoro-4-methoxyphenyl)-2-ox...)
Affinity DataEC50:  2.90nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetfMet-Leu-Phe receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631734(N-((3S, 4R)-4-(2, 6-Difluoro-4-methoxyphenyl)-2-ox...)
Affinity DataEC50:  14nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM631736(US20230348426, Example 6)
Affinity DataEC50:  5.10nMAssay Description: A mixture of forskolin (5 然 final for FPR2 or 10 然 final for FPR1) and IBMX (200 然 final) were added to 384-well Proxiplates (Perkin-Elmer) pre-d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 2107 total ) | Next | Last >>
Jump to: